azd5363
Showing 1 - 17 of 17
Breast Cancer, Prostate Cancer, Advanced Solid Tumors Trial in Middletown, Harrison, New York (AZD5363, Enzalutamide,
Active, not recruiting
- Breast Cancer
- +2 more
- AZD5363
- +2 more
-
Middletown, New Jersey
- +2 more
Jul 5, 2022
Advanced Solid Malignancy, Safety and Tolerability, Pharmacokinetics Trial in Worldwide (AZD5363)
Active, not recruiting
- Advanced Solid Malignancy
- +13 more
- AZD5363
-
Los Angeles, California
- +33 more
Dec 22, 2022
Prostate Cancer Trial in Southampton (Placebo, AZD5363)
Completed
- Prostate Cancer
- Placebo
- AZD5363
-
Southampton, Hampshire, United KingdomSouthampton General Hospital
May 4, 2022
Estrogen Receptor Positive Breast Cancer Trial in United Kingdom (AZD5363, Placebo, Fulvestrant)
Active, not recruiting
- Estrogen Receptor Positive Breast Cancer
- AZD5363
- +2 more
-
Manchester, Greater Manchester, United Kingdom
- +20 more
Aug 5, 2022
NSCLC Metastatic Trial in France (AZD2014, AZD4547, AZD5363)
Active, not recruiting
- Non-small Cell Lung Cancer Metastatic
- AZD2014
- +10 more
-
Avignon, France
- +36 more
Jul 29, 2022
Metastatic Breast Cancer Trial in France (AZD2014, AZD4547, AZD5363)
Active, not recruiting
- Metastatic Breast Cancer
- AZD2014
- +18 more
-
Angers, France
- +24 more
Mar 8, 2022
Advanced Cancer Trial in Newcastle, Sutton (olaparib, AZD5363)
Completed
- Advanced Cancer
- olaparib
- AZD5363
-
Newcastle, Newcastle Upon Tyne, United Kingdom
- +1 more
Jan 31, 2020
NSCLC, Carcinoma, Squamous Cell, Adenocarcinoma Trial in United Kingdom (AZD4547, Vistusertib, Palbociclib)
Active, not recruiting
- Non-Small Cell Lung Cancer
- +2 more
- AZD4547
- +10 more
-
Aberdeen, United Kingdom
- +24 more
Nov 2, 2021
Advanced Gastric Cancer Trial in Seoul (AZD5363, paclitaxel)
Completed
- Advanced Gastric Cancer
- AZD5363
- paclitaxel
-
Seoul, Seoul, Korea, Republic Of, Korea, Republic ofSamsung Medical Center
Dec 26, 2019
Advanced Gastric Adenocarcinoma Trial in Seoul (AZD5363, paclitaxel, AZD2014)
Terminated
- Advanced Gastric Adenocarcinoma
- AZD5363
- +2 more
-
Seoul, Korea, Republic ofSamsung Medical center
May 17, 2019
Adenocarcinoma of the Prostate Trial in Sutton (AZD5363, Enzalutamide)
Unknown status
- Adenocarcinoma of the Prostate
- AZD5363
- Enzalutamide
-
Sutton, Surrey, United KingdomRoyal Marsden Hospital
Aug 7, 2018
Advanced Breast Cancer Trial in United Kingdom (Fulvestrant, Neratinib, AZD5363)
Recruiting
- Advanced Breast Cancer
- Fulvestrant
- +4 more
-
Sutton, England, United Kingdom
- +18 more
Jan 17, 2019
Invasive Breast Cancer Trial in United Kingdom (AZD5363)
Completed
- Invasive Breast Cancer
- AZD5363
-
Derby, Derbyshire, United Kingdom
- +10 more
May 3, 2017
Advanced Solid Malignancy,, Safety and Tolerability,, Pharmacokinetics, Pharmacodynamics, Trial in Amsterdam, Manchester, Surrey
Completed
- Advanced Solid Malignancy,
- +3 more
- AZD5363
-
Amsterdam, Netherlands
- +2 more
Apr 19, 2016
Advanced Solid Malignancy, Advanced Solid Tumor Trial in Chuo-ku (AZD5363)
Completed
- Advanced Solid Malignancy
- Advanced Solid Tumor
- AZD5363
-
Chuo-ku, JapanResearch Site
Apr 25, 2016